| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2022 | Feb 17, 2022 | TuHURA Biosciences, Inc./NV | CEO | Buy | 91.3 | +55,000 | 100.00% | ✗ | $25.8K |
| Apr 30, 2018 | Jul 3, 2018 | HERON THERAPEUTICS, INC. /DE/ | CFO | Sell | 5.0 | -29,256 | -85.65% | ✓ | $1.1M |
| Oct 31, 2017 | Dec 20, 2017 | HERON THERAPEUTICS, INC. /DE/ | CFO | Buy | 90.0 | +536 | 100.00% | ✗ | $7K |